Diarrhea. Other gastroenteritis and colitis of infectious and unspecified origin
Conditions
Interventions
Intervention 1: Intervention group: First group recieve 1 suchet of Kidilact (for 2 to 5 years old) which is contains 1 gram of 10*9 microorganism, daily for 5 days. For each patient 5 suchet has been
Treatment - Drugs
Intervention group: First group recieve 1 suchet of Kidilact (for 2 to 5 years old) which is contains 1 gram of 10*9 microorganism, daily for 5 days. For each patient 5 suchet has been considered.
Intervention group: Second group receive synbiotic of Pedilact ( for 6 months to 2 years old) as 10 drops per day until 5 days. Pedilact is a oral drops which contain 15 cc in a bottle with 10*9 micro
Control group: Standard oral rehydration therapy with powder of ORS( in 1 liter cold boiled water). 10 cc per kilogram after each time of defecation until end of recuperation time
Sponsors
Vice chancellor for research, Sabzevar University of Medical Science
Eligibility
Sex/Gender
All
Age
6 Months to 5 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Signed informed consent form by patient's parents ; Patients between 6 months to 5 years old; Patients with acute diarrhea(less than 14 days). Exclusion criteria: Unwillingness of keeping the research up in any point with any excuse; Patient had severe diarrhea or need venous rehydratin; Patient had chronic diarrhea(more than 14 days); Consuming precedent of antibiotic in this diarrhea cycle; Presence of bloody diarrhea; Age less than 6 months or more than 5 years; Kid suffering from FTT(Failure To Thrive);The patient involved with other organs’ infections (Otitis, Pneumonia, Urinary Tract Infection and etc); The patient has utilized probiotics during a week ago; History of any kind of cancer in the past; Immunocompromised
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of diarrhea. Timepoint: 5 days after intervention and if diarrhea continues; daily. Method of measurement: Day. | — |
Secondary
| Measure | Time frame |
|---|---|
| Advers effect of drug. Timepoint: End of intervention. Method of measurement: Clinical evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohre Nazemi
Medical University of Medical Science
Outcome results
None listed